Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Initiation

Initiation

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Analyst Ratings
  • Initiation
  • News
  • Price Target

WestPark Capital Initiates Coverage On Okta with Buy Rating, Announces Price Target of $120

By Benzinga Newsdesk
March 17, 7:14 AM
WestPark Capital analyst Casey Ryan initiates coverage on Okta (NASDAQ:OKTA) with a Buy rating and announces Price Target of $120.

OKTA

Read More
1 minute read
  • Analyst Ratings
  • Initiation
  • News
  • Price Target

Baird Initiates Coverage On BILL Holdings with Neutral Rating, Announces Price Target of $86

By Benzinga Newsdesk
March 17, 4:55 AM
Baird analyst David Koning initiates coverage on BILL Holdings (NYSE:BILL) with a Neutral rating and announces Price Target of $86.

BILL

Read More
1 minute read
  • Analyst Ratings
  • Initiation
  • News
  • Price Target

Stifel Initiates Coverage On Viking Therapeutics with Buy Rating, Announces Price Target of $22

By Benzinga Newsdesk
March 17, 4:54 AM
Stifel analyst Annabel Samimy initiates coverage on Viking Therapeutics (NASDAQ:VKTX) with a Buy rating and announces Price Target of $22.

VKTX

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Biotech
  • General
  • Health Care
  • Initiation
  • Movers
  • News
  • Price Target
  • Small Cap
  • Trading Ideas

Stifel Is Bullish On This ‘Competitive Late-Comer’ In Gastric Cancer Space

By Vandana Singh
March 16, 1:47 PM
Stifel has initiated coverage on Theseus Pharmaceuticals Inc (NASDAQ:THRX) with a Buy rating and a $24 price target.  The company’s Predictive Resistance…

DCPH

Read More
1 minute read
  • Analyst Ratings
  • Initiation
  • News
  • Price Target

Exane BNP Paribas Initiates Coverage On Global Net Lease with Underperform Rating, Announces Price Target of $13

By Benzinga Newsdesk
March 16, 8:20 AM
Exane BNP Paribas analyst Nate Crossett initiates coverage on Global Net Lease (NYSE:GNL) with a Underperform rating and announces Price Target of $13.

GNL

Read More
1 minute read
  • Analyst Ratings
  • Initiation
  • News
  • Price Target

Berenberg Reinstates Hold on Cerevel Therapeutics Hldg, Announces $22 Price Target

By Benzinga Newsdesk
March 16, 7:25 AM
Berenberg analyst Caroline Palomeque reinstates Cerevel Therapeutics Hldg (NASDAQ:CERE) with a Hold and announces $22 price target.

CERE

Read More
1 minute read
  • Analyst Ratings
  • Initiation
  • News
  • Price Target

Ladenburg Thalmann Initiates Coverage On eMagin with Buy Rating, Announces Price Target of $3

By Benzinga Newsdesk
March 16, 7:24 AM
Ladenburg Thalmann analyst Glenn Mattson initiates coverage on eMagin (AMEX:EMAN) with a Buy rating and announces Price Target of $3.

EMAN

Read More
1 minute read
  • Analyst Ratings
  • Initiation
  • News
  • Price Target

Redburn Partners Initiates Coverage On Under Armour with Buy Rating, Announces Price Target of $13.5

By Benzinga Newsdesk
March 16, 7:14 AM
Redburn Partners analyst Geoffrey Lowery initiates coverage on Under Armour (NYSE:UAA) with a Buy rating and announces Price Target of $13.5.

UA

Read More
1 minute read
  • Analyst Ratings
  • Initiation
  • News
  • Price Target

Redburn Partners Initiates Coverage On Nike with Sell Rating, Announces Price Target of $100

By Benzinga Newsdesk
March 16, 7:10 AM
Redburn Partners analyst Geoffrey Lowery initiates coverage on Nike (NYSE:NKE) with a Sell rating and announces Price Target of $100.

NKE

Read More
1 minute read
  • Analyst Ratings
  • Initiation
  • News
  • Price Target

Needham Initiates Coverage On Recursion Pharmaceuticals with Buy Rating, Announces Price Target of $17

By Benzinga Newsdesk
March 16, 6:44 AM
Needham analyst Gil Blum initiates coverage on Recursion Pharmaceuticals (NASDAQ:RXRX) with a Buy rating and announces Price Target of $17.

RXRX

Posts pagination

Previous 1 … 59 60 61 … 272 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service